Dr. Elstrom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
706 Faxon Ave
San Francisco, CA 94112Phone+1 267-249-8265
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
- Emory University School of MedicineResidency, Internal Medicine, 1996 - 1999
- Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
- CA State Medical License 2013 - 2027
- NY State Medical License 2007 - 2013
- MI State Medical License 2005 - 2009
- PA State Medical License 1999 - 2006
- GA State Medical License 1997 - 1999
Publications & Presentations
PubMed
- 10 citationsAnti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study.Alex F Herrera, Manish R Patel, John M Burke, Ranjana Advani, Bruce D Cheson
Clinical Cancer Research. 2022-04-01 - 39 citationsZanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma.Constantine S. Tam, Hang Quach, Andrew Nicol, Xavier Badoux, Hannah Rose
Blood Advances. 2020-10-13 - 121 citationsTreatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase.Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu
Clinical Cancer Research. 2020-05-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: